Title | Type | SJR | H index | Total Docs. (2021) | Total Docs. (3years) | Total Refs. (2021) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2021) | %Female (2021) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Neuropharmacology | journal | 1.722 Q1 | 103 | 145 | 278 | 19000 | 2463 | 258 | 7.25 | 131.03 | 39.67 | |
2 | Current Medicinal Chemistry | journal | 0.800 Q2 | 202 | 400 | 1146 | 53423 | 5306 | 1047 | 4.20 | 133.56 | 44.01 | |
3 | Current Cancer Drug Targets | journal | 0.732 Q2 | 103 | 72 | 243 | 6575 | 863 | 231 | 2.78 | 91.32 | 42.58 | |
4 | Current Molecular Pharmacology | journal | 0.729 Q2 | 49 | 106 | 94 | 8305 | 359 | 90 | 3.87 | 78.35 | 35.73 | |
5 | Current Vascular Pharmacology | journal | 0.670 Q2 | 69 | 60 | 233 | 5338 | 657 | 196 | 3.27 | 88.97 | 40.09 | |
6 | Current Gene Therapy | journal | 0.656 Q2 | 80 | 40 | 123 | 3569 | 493 | 107 | 4.28 | 89.23 | 41.92 | |
7 | Current Drug Targets | journal | 0.654 Q2 | 119 | 139 | 451 | 13590 | 1581 | 431 | 2.91 | 97.77 | 38.96 | |
8 | Recent Patents on Anti-Cancer Drug Discovery | journal | 0.629 Q2 | 52 | 42 | 88 | 3536 | 322 | 85 | 2.84 | 84.19 | 44.10 | |
9 | Current Topics in Medicinal Chemistry | journal | 0.628 Q2 | 133 | 209 | 713 | 17357 | 2292 | 582 | 2.88 | 83.05 | 42.55 | |
10 | Current Radiopharmaceuticals | journal | 0.587 Q2 | 32 | 42 | 88 | 2366 | 325 | 78 | 2.63 | 56.33 | 44.33 | |
11 | Current Pharmaceutical Design | journal | 0.571 Q2 | 183 | 434 | 1532 | 41393 | 5157 | 1411 | 3.07 | 95.38 | 40.84 | |
12 | CNS and Neurological Disorders - Drug Targets | journal | 0.561 Q3 | 96 | 77 | 227 | 8044 | 744 | 213 | 2.79 | 104.47 | 38.24 | |
13 | Mini-Reviews in Medicinal Chemistry | journal | 0.512 Q3 | 107 | 181 | 393 | 19853 | 1484 | 386 | 3.51 | 109.69 | 40.67 | |
14 | Current Drug Delivery | journal | 0.460 Q2 | 72 | 132 | 299 | 8176 | 959 | 287 | 3.59 | 61.94 | 41.81 | |
15 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.403 Q3 | 108 | 206 | 647 | 13625 | 1619 | 632 | 2.26 | 66.14 | 46.40 | |
16 | Reviews on Recent Clinical Trials | journal | 0.386 Q3 | 35 | 49 | 131 | 1938 | 227 | 111 | 1.57 | 39.55 | 26.69 | |
17 | Current Drug Safety | journal | 0.333 Q3 | 41 | 36 | 121 | 2378 | 232 | 118 | 1.27 | 66.06 | 40.21 | |
18 | Medicinal Chemistry | journal | 0.323 Q3 | 50 | 96 | 254 | 4780 | 536 | 247 | 2.05 | 49.79 | 45.34 | |
19 | Current Nanoscience | journal | 0.310 Q3 | 52 | 76 | 225 | 6153 | 385 | 218 | 1.62 | 80.96 | 37.02 | |
20 | Current Computer-Aided Drug Design | journal | 0.258 Q4 | 32 | 82 | 151 | 3213 | 217 | 142 | 1.53 | 39.18 | 32.73 | |
21 | Combinatorial Chemistry and High Throughput Screening | journal | 0.244 Q4 | 70 | 168 | 286 | 7962 | 396 | 262 | 1.42 | 47.39 | 38.18 | |
22 | Letters in Drug Design and Discovery | journal | 0.213 Q3 | 37 | 96 | 421 | 4819 | 462 | 397 | 1.01 | 50.20 | 35.22 | |
23 | Current Pharmaceutical Analysis | journal | 0.177 Q3 | 27 | 114 | 308 | 4818 | 196 | 303 | 0.59 | 42.26 | 50.78 | |
24 | Current Drug Therapy | journal | 0.175 Q3 | 20 | 40 | 88 | 1989 | 77 | 86 | 0.86 | 49.73 | 39.74 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®